Drries patent opposition analysis

The comprehensive analysis of Drries opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Drries

Patent NumberTitleApplicantOpposition DateOpposition Company
A Stable Liquid Formulation Of Fusion Protein With Igg Fc DomainALTEOGENAug 25, 2025DRRIES
A Stable Liquid Formulation Of Fusion Protein With Igg Fc DomainALTEOGENAug 25, 2025DRRIES
Mutated Glycoprotein Of Vesicular Stomatitis VirusUNIVERSIT PARIS SACLAYMay 14, 2025DRRIES
Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRSJan 15, 2025DRRIES
Methods For Treating Skin Infection By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYNov 13, 2024DRRIES
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGYNov 7, 2024DRRIES
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of CancerTRON TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITTSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITT MAINZ GEMEINNTZIGEOct 10, 2024DR H ULRICH DRRIES
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYOct 1, 2024DR H ULRICH DRRIES
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYAug 1, 2024DR H ULRICH DRRIES
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJul 3, 2024DR H ULRICH DRRIES

Top companies who are the clients of Drries